Organization | National Science Centre, Poland

National Science Centre, Poland Report issue

Government Phase 3 Phase 4

Founded: Krakow Poland (2011)

Organization Overview

First Clinical Trial

2011

NCT03028649

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

National Science Centre, Poland

Active Ingredients

Drugs in Phase 4 Trials (1)

omeprazole (prilosec) (1 trial)

Drugs in Phase 3 Trials (4)

beta-hydroxyisovaleric acid (1 trial)

betaine (1 trial)

caffeine (1 trial)

hydroxymethylbutyrate (2 trials)

Drugs in Other Trials (6)

cocoa powder (1 trial)

icosapent ethyl (vascepa) (1 trial)

leucine (1 trial)

levocarnitine (carnitor) (1 trial)

omega-3 fatty acids (Omacor) (1 trial)

s-adenosyl methionine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Gastrointestinal Hemorrhage (Phase 4)

Hemorrhage (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 11
# of Trial APIs: 11